Rovensa Next Appoints Javier de Benito as Chief Operations Officer
23 September 2026, Madrid: Rovensa Next has appointed Javier de Benito as Chief Operations Officer (COO), a newly created role aimed at strengthening global
Read MoreRovensa Next covers the latest news, product launches, business developments, research initiatives, sustainability programs, partnerships, and innovations from the global biosolutions company. Read about biostimulants, biofertilizers, biocontrol products, specialty nutrition, sustainable crop management, regenerative agriculture, plant health solutions, and developments shaping the future of sustainable farming.
23 September 2026, Madrid: Rovensa Next has appointed Javier de Benito as Chief Operations Officer (COO), a newly created role aimed at strengthening global
Read More11 September 2026, Madrid: Rovensa Next, a global biosolutions company focused on sustainable agriculture, has secured R$45 million (approximately US$8.8 million) in financing from
Read More25 June 2026, Spain: Rovensa Next, a global leader in agricultural biosolutions, is playing a key role in the BIO2 initiative, a €6.4
Read More15 June 2026, North Carolina: Novonesis and Rovensa Next today announced a distribution agreement under which Rovensa Next will commercialize select Novonesis
Read More13 June 2026, North Carolina: Novonesis and Rovensa Next have signed a distribution agreement under which Rovensa Next will commercialize selected Novonesis agricultural biosolutions in
Read More28 May 2026, Madrid: Rovensa Next has launched Luxyva® in Mexico, a biosolution developed to support crop performance under conditions of high solar
Read More16 April 2026, Madrid: Rovensa Next has launched a global capability-building program that uses artificial intelligence and structured training to strengthen
Read More10 March 2026, Madrid: Rovensa Next has announced the launch of Otimais Duo, a high-performance dual-microbial inoculant in Brazil designed to maximize nutrient-use
Read More24 February 2026, Madrid: Rovensa Next has announced the launch of two biosolutions in the North American market, TYPHOON® and GALACTEK®. The
Read More29 January 2026, Madrid: Rovensa Next is participating as a research partner in the FAUVE project, led by the Université de
Read More